Lippman Evan — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Lippman Evan has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.48M.

Profile

Lippman Evan

Evan Lippman is associated with Teva Pharmaceutical Industries Ltd, a global pharmaceutical company known for its generic and specialty medicines. Specific details about his role or contributions are not widely documented.

RoleInsider
Notability20/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-18TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS — Open-market sale35.9K$35.58$1.28M
2026-05-18TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM — Option exercise74.0K—
2026-05-18TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS — Open-market sale5.7K$35.58$204K
2026-05-18TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM — Option exercise11.8K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Lippman Evan?

Evan Lippman is associated with Teva Pharmaceutical Industries Ltd, a global pharmaceutical company known for its generic and specialty medicines. Specific details about his role or contributions are not widely documented.…

How many SEC Form 4 filings has Lippman Evan submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Lippman Evan been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.48M) across all tracked filings.

Where can I see all of Lippman Evan's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Lippman Evan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.